![]() |
![]() |
|
![]() |
||
|
|
IPRs, biotechnology and developmentDeveloping countries are being urged to introduce strong intellectual property rights (IPRs) to enable poor farmers to take advantage of genetically modified crops. IPRs can stimulate trade, investment, innovation and technology transfer for development. However, for many developing countries, the costs of IPR regimes outweigh the benefits and may undermine long-term development. IPRs do little to encourage private research into crops and traits important to food security and often impede public research that could address these needs.
IPRs provide a vital incentive for investment in expensive biotechnological research. They give companies the safeguards necessary to encourage them to commercialise their products in developing countries. Agreed standards of IPR protection have been introduced at a global level, mainly through the World Trade Organisation's (WTO) Agreement on Trade-Related Intellectual Property Rights (TRIP). This requires developing countries to implement strong domestic IPR regimes. This has several consequences for the biotechnology sector, including:
A study by the independent UK Commission on Intellectual Property Rights confirms that IPRs may only benefit developing countries with a high level of manufacturing and innovation capacity. For the poorest countries, the costs of strong IPRs outweigh the short-term benefits and potentially the long-term benefits as well. IPRs do little to stimulate investment where there is unlikely to be a profitable market for the end product. While IPRs may interest private investors in cash crops grown in developing countries, they are not effective in attracting investment in subsistence crops, or traits relevant to poor farmers or food security. Also patents may restrict farmers' conventional rights to save and exchange seeds. Developing countries should tailor their IPR regimes to their national circumstances and developmental priorities. This will require:
Few developing countries appear to be following this approach. Many rely on multilateral, bilateral and private support, which generally favours strong IPR models. In addition, many developing countries have foregone TRIP's flexibility to maintain key bilateral trade, aid and investment relationships with wealthy countries. Courts and patent offices in developed countries have interpreted intellectual property laws in a manner that supports the biotechnology industry's demands for strong IPRs. The consensus that strong IPRs are good for development seems to be entrenched amongst policy-makers. Nevertheless, it is coming under increasing scrutiny. The following policy responses are suggested:
Farhana Yamin CIPR report available from: www.iprcommission.org See also Yamin, F. (2003) Intellectual property rights, biotechnology and food security. IDS Working Paper 203 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Views expressed on these pages are not necessarily those of DFID, IDS, id21 or other contributing institutions. Copyright remains with the original authors but (unless stated otherwise) articles may be copied or quoted without restriction, provided id21 and originating author(s) and institution(s) are acknowledged. Copyright © 2005 id21. All rights reserved. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||